NeuBase Therapeutics, Inc.
NBSEDelisted May 16, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001173281
NeuBase Therapeutics, Inc. was delisted on May 16, 2024; its insiders filed their last Form 4 on Sep 18, 2023; 18 institutions reported holding it in 13F filings for Q1 2024, worth $177.1K in total; Greenlight Capital was the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding NeuBase Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 43 | 44 | +1 |
| Shares | 12.8M | 12.0M | −770.9K (−6.0%) |
| Value | $13.4M | $4.74M | −$8.64M (−64.6%) |
New holders (7)
Institutions that held NeuBase Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 31,992 | $13.0K | 0.00% |
| Millennium Management LLC | 22,309 | $9.00K | 0.00% |
| Citadel Advisors LLC | 22,799 | $9.00K | 0.00% |
| Mariner, LLC | 15,500 | $6.00K | 0.00% |
| Jane Street Group, LLC | 14,156 | $6.00K | 0.00% |
| JPMorgan Chase & Co | 25 | $0 | 0.00% |
| Simplex Trading, LLC | 171 | $0 | 0.00% |
Sold out (6)
Institutions that held NeuBase Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Deutsche Bank AG | 100,000 | $105.0K |
| UBS Group AG | 2,457 | $3.00K |
| Cubist Systematic Strategies, LLC | 1,839 | $2.00K |
| Venture Visionary Partners LLC | 665 | $698 |
| Schonfeld Strategic Advisors LLC | 12,714 | $0 |
| Global Wealth Management Investment Advisory, Inc. | 250 | $0 |